BiotechTube
Home/KeyZell/Miguel Vilaplana
MV

Miguel Vilaplana

Chairman

KeyZell

Therapeutic Areas

Oncology

KeyZell Pipeline

DrugIndicationPhase
LZ-167Oncology (specific indications not disclosed)Pre-clinical

Leadership Team at KeyZell

JD
José del Corral
Chief Executive Officer (CEO)
DN
Dr. Nabil Hajji
Investigator
View full KeyZell profile